An antibody or a functional fragment thereof that specifically binds to IL-17A with high affinity. A nucleic acid molecule encoding said antibody or functional fragment thereof, an expression vector and a host cell for expressing the antibody or the functional fragment thereof, and a method for producing the antibody or the functional fragment thereof. A pharmaceutical composition comprising the antibody or the functional fragment thereof and a method for treating immune dysfunction using the antibody or the functional fragment thereof.
